Published in Virology on April 15, 1982
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. J Virol (1989) 1.20
Uneven distribution of methylation sites within the human papillomavirus la genome: possible relevance to viral gene expression. Nucleic Acids Res (1984) 1.07
Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions. J Virol (1991) 0.96
Alterations in the regulatory region of the human papillomavirus type 6 genome are generated during propagation in Escherichia coli. J Virol (1988) 0.86
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol (1984) 13.69
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med (2001) 5.09
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer (1982) 4.30
Nucleotide sequence of cro, cII and part of the O gene in phage lambda DNA. Nature (1978) 4.12
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene (1987) 4.02
Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation (2000) 3.75
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (1987) 3.70
Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J Virol (1982) 3.16
Human papilloma viruses (HPV): characterization of four different isolates. Virology (1977) 2.99
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol (1999) 2.70
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene (1984) 2.44
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A (1987) 2.40
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart (2007) 2.40
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Lymphotropic papovaviruses isolated from African green monkey and human cells. Med Microbiol Immunol (1979) 2.23
Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol (1992) 2.19
Functional analysis of the replicator structure of lambdoid bacteriophage DNAs. Cold Spring Harb Symp Quant Biol (1979) 2.18
Mdj1p, a novel chaperone of the DnaJ family, is involved in mitochondrial biogenesis and protein folding. Cell (1994) 2.12
Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol (1993) 2.10
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology (2004) 2.09
A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology (1985) 2.07
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer (1987) 2.03
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation (2001) 2.02
Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet (1978) 2.00
Genetic interactions of modifier genes and modifiable alleles in Drosophila melanogaster. Genetics (1988) 1.99
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation (1986) 1.99
Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97
Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg (2000) 1.94
NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology (1980) 1.92
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res (1988) 1.89
Two distant clusters of partially homologous small repeats of Epstein-Barr virus are transcribed upon induction of an abortive or lytic cycle of the virus. J Virol (1983) 1.82
Patent foramen ovale and neurosurgery in sitting position: a systematic review. Br J Anaesth (2009) 1.82
A gene coding for tRNA is located near 5' terminus of 16S rRNA gene in Zea mays chloroplast genome. Proc Natl Acad Sci U S A (1981) 1.81
Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol (1984) 1.80
Nucleotide sequence of the cro-cII-oop region of bacteriophage 434 DNA. Nucleic Acids Res (1979) 1.78
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol (2001) 1.76
Human papilloma virus DNA: physical mapping and genetic heterogeneity. Proc Natl Acad Sci U S A (1976) 1.76
Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol (1998) 1.75
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Electroelution of fixed and stained membrane proteins from preparative sodium dodecyl sulfate-polyacrylamide gels into a membrane trap. Anal Biochem (1986) 1.72
The glucose kinase gene of Streptomyces coelicolor A3(2): its nucleotide sequence, transcriptional analysis and role in glucose repression. Mol Microbiol (1992) 1.72
Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer (1985) 1.71
Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol (1998) 1.70
HDF2, the second subunit of the Ku homologue from Saccharomyces cerevisiae. J Biol Chem (1996) 1.68
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation (1999) 1.66
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology (1997) 1.66
Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry (2002) 1.63
Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn (1995) 1.62
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart (2005) 1.61
Stenting of superior vena cava and inferior vena cava for symptomatic narrowing after repeated atrial surgery for D-transposition of the great vessels. Br Heart J (1991) 1.59
Structure and evolution of two related transcription units of Epstein-Barr virus carrying small tandem repeats. J Virol (1985) 1.59
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc (2000) 1.58
Prevention of stroke in patients with patent foramen ovale. Int J Stroke (2010) 1.57
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology (1988) 1.56
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Viruses in the etiology of human genital cancer. Prog Med Virol (1984) 1.54
Seminal tract infections: impact on male fertility and treatment options. Hum Reprod Update (1999) 1.49
Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization. Eur Heart J (2000) 1.49
Aortic dissection as complication of percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn (1992) 1.48
A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization. Mol Biol Cell (2000) 1.48
Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol (1985) 1.47
Indications for intracoronary stent placement: the european view. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.46
Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol (2001) 1.46
Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am J Trop Med Hyg (1973) 1.45
Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol (1999) 1.45
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44